← Back to Search

AI Chatbot for Urogynecologic Conditions

N/A

Recruiting

Led By Elena Tuntisky-Bitton, MD

Research Sponsored by Hartford Hospital

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Aged greater than or equal to 18 and less than or equal to 89 years old

Be older than 18 years old

Must not have

Non-English or non-Spanish speaking

Male

Timeline

Screening 3 weeks

Treatment Varies

Follow Up three month follow-up

Awards & highlights

No Placebo-Only Group

Summary

"This trial aims to study how Urogynecology patients use an Artificial Intelligence (AI) Chatbot called ChatGPT and how it impacts their healthcare decisions. The trial will investigate how the AI Chat

Who is the study for?

This trial is for patients experiencing urinary incontinence, lower urinary tract symptoms, or uterovaginal prolapse. Participants should be seeking urogynecology consultation and willing to interact with an AI chatbot like ChatGPT as part of their healthcare decision-making process.

What is being tested?

The study tests how using the ChatGPT AI chatbot affects patient understanding of their condition and satisfaction with urogynecology consultations. It also evaluates the accuracy of diagnoses and advice provided by the chatbot. The timing of chatbot use (before or after a doctor's visit) will be compared.

What are the potential side effects?

Since this trial involves using an AI chatbot for information, there are no direct medical side effects. However, potential risks may include misinformation if the AI provides inaccurate advice or diagnosis.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am between 18 and 89 years old.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I do not speak English or Spanish.

Select...

I am male.

Select...

My main health issue is not related to urinary or pelvic problems.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline and three month follow-up

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline and three month follow-up

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline and three month follow-up for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Patient understanding of diagnosis and treatment - decision making

Patient understanding of diagnosis and treatment - participant understanding of diagnosis and treatment plan

Patient understanding of diagnosis and treatment - physician perception of participant understanding

+2 more

Secondary study objectives

Chatbot information accuracy

Patient Chatbot use after urogynecology visit

Patient satisfaction - Chatbot

+1 more

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

3Treatment groups

Experimental Treatment

Active Control

Group I: Pre-Visit ChatGPT UseExperimental Treatment1 Intervention

After being consented, the participant will be provided with ChatGPT-4 application and a brief orientation to the program. The participant will then be instructed to ask ChatGPT about the participant's primary presenting problem with will be discussed at their urogynecology consultation. The participant will be allowed up to five follow-up/clarification entries into the Chat GPT program, but may finish asking questions at any time. This should take no more than five minutes of the participant's time. After completing this, the participant will be returned to the waiting room, and will proceed through the urogynecology visit as normal.

Group II: Post-Visit ChatGPT UseExperimental Treatment1 Intervention

After being consented, the participant will be returned to the waiting room and will proceed through the urogynecology visit as normal. After the visit, the participant will be provided with ChatGPT-4 application and a brief orientation to the program. The participant will then be instructed to ask ChatGPT about the participant's primary presenting problem with will be discussed at their urogynecology consultation. The participant will be allowed up to five follow-up/clarification entries into the Chat GPT program, but may finish asking questions at any time. This should take no more than five minutes of the participant's time. After completing this, the participant will be allowed to leave the visit.

Group III: No ChatGPT UseActive Control1 Intervention

After undergoing the consent process, participants will be returned to the waiting room to await the beginning of the appointment. The participant will complete the urogynecology visit as normal.

0 / 4Eligibility criteria met